2022 AHA/ACC/HFSA heart failure guideline
The 2022 heart failure guideline from the American Heart Association, the American College of Cardiology and the Heart Failure Society of America. Its abstract says it replaces the 2013 guideline and the 2017 focused update, and that it gives patient-centered recommendations for preventing, diagnosing and managing heart failure. The page for the four-class regimen lists the four medicine classes that an ACC summary names, and the pages of two medicine classes carry the class 1a statements of the summary, because the guideline text was not read.
- Guideline
- In this atlas
Overview
Technical summary
Circulation 2022;145(18):e895-e1032, doi 10.1161/CIR.0000000000001063, PMID 35363499. Electronic publication 2022-04-01. Issued by the joint ACC/AHA committee on clinical practice guidelines. The Heart Failure Society of America is named in the title and has no record in this atlas. PubMed lists three corrections (2022-05-03, 2022-09-27 and 2023-04-04); their text was not read. The ACC summary page is a separate source and is cite only.
About this guideline
- Edition
- 2022 guideline
- Published
- 2022-04-01
- Status
- Not checked for a newer edition
Source
- Document
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
- Publisher
- Circulation
- Edition note
- Published in Circulation 145(18):e895-e1032 (issue date 2022-05-03; electronic publication 2022-04-01). PubMed abstract and bibliographic data only. PubMed lists no PMC copy. The guideline text was not read. PubMed lists 3 corrections to the guideline; their text was not read. The same source also holds a snapshot of the ACC key-perspectives summary page of the guideline (dated Apr 01, 2022), which is an ACC summary and not the guideline text. The recommendation text for this atlas comes from that page. The publisher field is the journal title as PubMed gives it.
Recommendations
- Recommended: SGLT2 inhibitors (drug class)
Record details
- Record id
cardio:guideline-aha-acc-hfsa-2022-heart-failure- Content hash
c35248e87043930d13a3d70157fd1c7f5aac2bb60f0013d550aa2cda9e1f331f